PFE - CStone completes $200M share sale to Pfizer

CStone Pharmaceuticals (CSPHF) has completed the Share Subscription Agreement through which an affiliate of Pfizer (PFE) subscribed for newly issued CStone shares at ~$200M (~HK$1.55B), bringing into effect the strategic collaboration announced previously. The Hong Kong Stock Exchange has approved the listing of 115,928,803 additional shares at ~HK$13.37/share, representing ~9.90% of the issued share capital of CStone.Previously: Pfizer inks deal with CStone for oncology assets in China; acquires 9.9% stake (Sept. 29)

For further details see:

CStone completes $200M share sale to Pfizer